Biotechnology · Healthcare
Chief Accounting Officer
2024-08-14–present
Chief Accounting Officer
Tenaya Therapeutics, Inc. (TNYA)Equibles does not estimate personal net worth.
Get an email with a short summary when Tenaya Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get TNYA alertsChihiro Saito is recorded as Chief Accounting Officer at Tenaya Therapeutics, Inc. (TNYA) since August 14, 2024. Tenaya Therapeutics, Inc. reported in an 8-K filed December 17, 2024 that Chihiro Saito resigned as Senior Vice President, Accounting and Financial Operations, effective December 16, 2024. Tenaya Therapeutics, Inc. reported in an 8-K filed August 8, 2024 that Chihiro Saito was appointed Interim Principal Accounting Officer, effective August 14, 2024. Tenaya Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Tenaya Therapeutics, Inc. includes Faraz Ali (CEO, CFO and Board Member), Eric Hyllengren (CFO), Tomohiro Higa (Chief Accounting Officer) and 7 others.
“On December 16, 2024, Ms. Chihiro Saito, Senior Vice President, Accounting and Financial Operations (“SVP, AFO”) and Interim Principal Accounting Officer (“Interim PAO”) of Tenaya Therapeutics, Inc. (“Tenaya” or the “Company”) advised the Company that she was resigning from her role as SVP, AFO and Interim PAO to pursue another opportunity.”
“Effective August 14, 2024, upon Ms. Patterson ceasing to be PAO, Ms. Chihiro Saito, Tenaya's Senior Vice President, Accounting and Financial Operations, will assume the role of Interim PAO for the Company in addition to her role as Senior Vice President, Accounting and Financial Operations.”
2024-08-14–present
Biotechnology · Healthcare
Chief Accounting Officer
2024-08-14–present